Literature DB >> 35879493

Molecularly imprinted and cladded nanoparticles for high-affinity recognition of structurally closed gangliosides.

Zhanchen Guo1, Menghuan Zhao1, Zhen Liu2.   

Abstract

A new method called reverse microemulsion-confined ganglioside-oriented surface imprinting and cladding (RM-GOSIC) is presented for controllable preparation of nanoscale binders for high-affinity targeting gangliosides. Using GM1a, an affordable ganglioside, as a representative ganglioside target, single-core quantum dot GM1a-imprinted and GM1a-cladded polymer (cMIP) nanoparticles were prepared. The prepared cMIP nanoparticles exhibited extremely high affinity towards GM1a, with dissociation constant at the nanomolar level (3-6 nM). The prepared cMIP nanoparticles also recognized structurally closed gangliosides while their cross-reactivity towards other gangliosides remained low. The potential of the cMIP nanoparticles in biomedical applications was demonstrated by cell and tissue imaging. Thus, this approach opened a new access to the synthesis of high-affinity nanoscale binders for targeting gangliosides.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Biomedical applications; Cell imaging; Gangliosides; Glycans; Molecular imprinting; Nanoparticles; Tissue imaging

Mesh:

Substances:

Year:  2022        PMID: 35879493     DOI: 10.1007/s00604-022-05395-2

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   6.408


  28 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 2.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 3.  Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain.

Authors:  S I Hakomori
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 4.  Gangliosides: glycosphingolipids essential for normal neural development and function.

Authors:  Cara-Lynne Schengrund
Journal:  Trends Biochem Sci       Date:  2015-05-01       Impact factor: 13.807

5.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.

Authors:  E G Bremer; J Schlessinger; S Hakomori
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

6.  Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Authors:  K Blennow; P Davidsson; A Wallin; P Fredman; C G Gottfries; I Karlsson; J E Månsson; L Svennerholm
Journal:  Arch Neurol       Date:  1991-10

Review 7.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

8.  Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin.

Authors:  Evelyne Gout; Virginie Garlatti; David F Smith; Monique Lacroix; Chantal Dumestre-Pérard; Thomas Lunardi; Lydie Martin; Jean-Yves Cesbron; Gérard J Arlaud; Christine Gaboriaud; Nicole M Thielens
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

Review 9.  Glycosylation in health and disease.

Authors:  Colin Reily; Tyler J Stewart; Matthew B Renfrow; Jan Novak
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 42.439

10.  Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.

Authors:  T N Seyfried; H Choi; A Chevalier; D Hogan; Z Akgoc; J S Schneider
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.